This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are. The Health and Human Services Department on Thursday announced a sweeping plan to cut 10,000 jobs and consolidate operations across its sub-agencies. FDA drug, medical device, or food reviewers and inspectors will not be among those fired, according to an HHS fact sheet.
Introduction Social media advertising has undergone a major transformation in the pharmaceutical industry over the past decade. What once was a cautious, slow-moving experiment has now become a vital component of modern pharma marketing strategies. The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers.
When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.
On March 26, 2025, the FDA approved Fresenius Kabis denosumab biosimilars, CONEXXENCE (denosumab-bnht) and BOMYNTRA (denosumab-bnht), referencing Amgens PROLIA and XGEVA, respectively. These approvals make Fresenius the fourth company to receive FDA approval for a pair of denosumab biosimilars, joining Celltrion , Samsung , and Sandoz. Denosumab is a RANK ligand (RANKL) inhibitor that is used to treat bone loss.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
WASHINGTON — Sen. Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr. as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines. On Thursday morning, Cassidy said, the two had breakfast to discuss Kennedy’s plans to lay off 10,000 Health and Human Services Department employees.
Along with shrinking the HHS’ workforce further, the reorganization announced Thursday will cut the department from 28 divisions to 15, and close five regional offices.
130
130
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Along with shrinking the HHS’ workforce further, the reorganization announced Thursday will cut the department from 28 divisions to 15, and close five regional offices.
A disease detection chatbot powered by generative AI and four cancer tests are among the latest medical devices to receive “breakthrough” status from the Food and Drug Administration. The FDA granted breakthrough designation to devices from at least 15 medical technology companies between December and mid-March, STAT found. You can learn more about these, as well as other devices that have so far received the designation, using STAT’s Breakthrough Device Tracker.
After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma giants are even more ambitious for the next wave of biologic medicines.
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. This is the one-year anniversary edition of the Biotech Scorecard newsletter! I have poured my heart and soul into this endeavor. It’s been immensely gratifying, and I’m deeply grateful to all of you for the attention you’ve given it over the past 12 months.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Health and Human Services Department is set to cut 10,000 jobs and consolidate divisions under Secretary Robert F. Kennedy Jr. We are eager to hear from readers who have been impacted by the mass layoffs and restructuring at the agency and others under its umbrella.
The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Nominated by the HBAs Corporate Partners, these leaders are not only exceptional contributors within their companies but also powerful advocates for health equity and women’s advancement globally, significantly contributing to the HBAs vision of Creating Women Leaders for Life.
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Earlier this week, the Peterson Health Technology Institute (PHTI) issued a report that assesses health systems’ experience with AI ambient scribes so far and zeroing in on the technology’s “financial and operational implications.
As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. The House of Lords Science and Technology Committee recently warned that the country is in a global competition for talent and that its visa system risks holding it back.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Let’s get straight into the news today.
Logista Freight has found that Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in pharmaceutical products in the EU-27. Furthermore, trade from Ireland to Belgium, from Germany to the Netherlands and from the Netherlands to Germany occupy the highest trade positions. Logista Freight is a logistics company which specialises […] The post Five of EU-27 account for 68% of pharma trade, report finds appeared first on Pharmafile.
Revolutionizing Generic Drug Development: The Power of Digital Transformation As the pharmaceutical industry continues to evolve, one thing is clear: digital transformation is no longer a luxury, but a necessity. At the forefront of this revolution is the generic drug development sector, where innovative technologies are streamlining processes, reducing costs, and improving patient outcomes.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology company, announced that they have entered into a global license agreement for Puhe BioPharma's oral, small molecule PRMT5 inhibitor that selectively targets MTAP-deleted tumors. Under the agreement, Bayer obtains an exclusive worldwide license to develop, manufacture and commercialize the MTA-cooperative PRMT5 inhibitor.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The biotech is slashing a third of its workforce and more than half of its executive team in moves it called “necessary in today’s challenging financial and competitive environment.
The share acquisition is the latest twist in a dispute between Alcon and fellow Aurion shareholder Deerfield Management over the direction of the company, which filed to go public in January.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
346 
Let's personalize your content